1.Clinical and laboratory study of a newly observed viral infection in the Philippines: A preliminary report
Milagros P. Reyes ; Alendry P. Caviles, Jr. ; Lourdes A. Manahan ; Lourdes Espiritu-Campos ; Paulo C. Campos
Acta Medica Philippina 2022;56(2):6-9
Eighteen (18) cases of Chikungunya (or a very close related virus) infection, a newly observed clinical entity in the Philippines, are presented. Diagnosis was established by serological studies consisting of hemagglutination- inhibition (HI) and complement fixation (CF) tests.
The clinical picture is characterized by a symptom-complex consisting essentially of fever, severe, incapacitating, recurrent joint pains and a rash. There is no involvement of the respiratory system and no bleeding tendencies were observed. The erythrocyte sedimentation rate was elevated, more so towards the later part of the illness. The platelet counts were normal. No residual joint deformity morbidity or mortality was encountered.
Chikungunya virus
2.Progress on the study of Chikungunya disease.
Mei-yu FANG ; Jian-wei LIU ; Rui-wen REN
Chinese Journal of Epidemiology 2008;29(10):1042-1044
3.Chikungunya virus infection.
The Medical journal of Malaysia 2006;61(2):264-9
Chikungunya virus (CHIKV) is a mosquito-borne alphavirus which causes epidemic fever, rash and polyarthralgia in Africa and Asia. Two outbreaks have been reported in Malaysia, in Klang, Selangor (1998) and Bagan Panchor, Perak (2006). It is not known if the outbreaks were caused by the recent introduction of CHIKV, or if the virus was already circulating in Malaysia. Seroprevalence studies from the 1960s suggested previous disease activity in certain parts of the country. In Asia, CHIKV is thought to be transmitted by the same mosquitoes as dengue, Aedes aegypti and Ae. albopictus. Due to similarities in clinical presentation with dengue, limited awareness, and a lack of laboratory diagnostic capability, CHIKV is probably often underdiagnosed or misdiagnosed as dengue. Treatment is supportive. The prognosis is generally good, although some patients experience chronic arthritis. With no vaccine or antiviral available, prevention and control depends on surveillance, early identification of outbreaks, and vector control. CHIKV should be borne in mind in sporadic cases, and in patients epidemiologically linked to ongoing local or international outbreaks or endemic areas.
increasing incidence
;
Dengue
;
Chikungunya virus
;
Infection as complication of medical care
;
control
4.Chikungunya fever.
Chinese Journal of Virology 2011;27(4):372-377
5.Nature of Complex Network of Dengue Epidemic as a Scale-Free Network
Hafiz Abid Mahmood MALIK ; Faiza ABID ; Nadeem MAHMOOD ; Mohamed Ridza WAHIDDIN ; Asif MALIK
Healthcare Informatics Research 2019;25(3):182-192
OBJECTIVES: Dengue epidemic is a dynamic and complex phenomenon that has gained considerable attention due to its injurious effects. The focus of this study is to statically analyze the nature of the dengue epidemic network in terms of whether it follows the features of a scale-free network or a random network. METHODS: A multifarious network of Aedes aegypti is addressed keeping the viewpoint of a complex system and modelled as a network. The dengue network has been transformed into a one-mode network from a two-mode network by utilizing projection methods. Furthermore, three network features have been analyzed, the power-law, clustering coefficient, and network visualization. In addition, five methods have been applied to calculate the global clustering coefficient. RESULTS: It has been observed that dengue epidemic follows a power-law, with the value of its exponent γ = −2.1. The value of the clustering coefficient is high for dengue cases, as weight of links. The minimum method showed the highest value among the methods used to calculate the coefficient. Network visualization showed the main areas. Moreover, the dengue situation did not remain the same throughout the observed period. CONCLUSIONS: The results showed that the network topology exhibits the features of a scale-free network instead of a random network. Focal hubs are highlighted and the critical period is found. Outcomes are important for the researchers, health officials, and policy makers who deal with arbovirus epidemic diseases. Zika virus and Chikungunya virus can also be modelled and analyzed in this manner.
Administrative Personnel
;
Aedes
;
Arboviruses
;
Chikungunya virus
;
Critical Period (Psychology)
;
Dengue Virus
;
Dengue
;
Humans
;
Methods
;
Zika Virus
6.Western Blot Detection of Human Anti-Chikungunya Virus Antibody with Recombinant Envelope 2 Protein.
Zhaoshou YANG ; Jihoo LEE ; Hye Jin AHN ; Chom Kyu CHONG ; Ronaldo F DIAS ; Ho Woo NAM
The Korean Journal of Parasitology 2016;54(2):239-241
Chikungunya virus (CHIKV), a tropical pathogen, has re-emerged and has massive outbreaks abruptly all over the world. Containing many dominant epitopes, the envelope E2 protein of CHIKV has been explored for the vaccination or diagnosis. In the present study, the antigenicity of a recombinant expressed intrinsically disorder domain (IUD) of E2 was tested for the detection of the antibody against CHIKV through western blot method. The gene of the IUD of E2 was inserted into 2 different vectors and expressed as recombinant GST-E2 and recombinant MBP-E2 fusion protein, respectively. Two kinds of fusion proteins were tested with 30 CHIKV patient sera and 30 normal sera, respectively. Both proteins were detected by 25 patients sera (83.3%) and 1 normal serum (3.3%). This test showed a relatively high sensitivity and very high specificity of the recombinant E2 proteins to be used as diagnostic antigens against CHIKV infection.
Blotting, Western*
;
Chikungunya virus
;
Diagnosis
;
Disease Outbreaks
;
Epitopes
;
Humans*
;
Sensitivity and Specificity
;
Vaccination
8.Virus-like particle-based immunoglobulin M capture enzyme-linked immunosorbent assay for the detection of IgM antibodies against Chikungunya virus.
Jian-dong LI ; Quan-fu ZHANG ; Shuo ZHANG ; Chuan LI ; Qin-zhi LIU ; Mi-fang LIANG ; De-xin LI
Chinese Journal of Virology 2014;30(6):599-604
To establish a MacELISA method for the detection of IgM antibodies against Chikungunya virus (CHIKV), we prepared virus like particle (VLP) antigens of CHIKV using the whole structural protein C-E3-E2-6K-E1 encoding gene with a baculovirus expression system in Sf9 insect cells. The VLPs were purified and used to immunize Kunming mice. Then, polyclonal antibodies were purified from the samples of ascites with a protein G HiTrap SP column and labeled with horseradish peroxidase. A MacELISA method for the detection of IgM antibodies against CHIKV was assembled with goat anti-human IgM antibody, VLP antigens and an enzyme-labeled polyclonal antibody. The results were evaluated with a serum panel containing serum samples from laboratory-confirmed CHIK, HFRS patients, healthy donors, and commercially available CHIKV IgM as a quality control. It was shown that the MacELISA had a specificity of 99% (99/100), the coefficients of variation (CoV) within a plate were <10%, and the CoV of different ELISA plates in terms of the plate variation coefficient was <15%. A comparative analysis was performed to compare the current method against a commercial CHIKV IgM antibody detection kit for IIFA-IgM. The detection limit of MacELISA was significantly lower than that of the IIFA-IgM commercial kit (P< 0.0001). Here, we demonstrate that the VLP-based MacELISA is a promising tool for the early diagnosis and epidemiological investigation of CHIKV infection, with a high level of sensitivity and specificity for the detection of IgM antibodies against CHIKV.
Animals
;
Antibodies, Viral
;
blood
;
Chikungunya Fever
;
blood
;
diagnosis
;
virology
;
Chikungunya virus
;
immunology
;
isolation & purification
;
Enzyme-Linked Immunosorbent Assay
;
methods
;
Humans
;
Immunoglobulin M
;
blood
;
Mice
9.Polyarthritis in four patients with chikungunya arthritis.
Nai Lee LUI ; Hoe Nam LEONG ; Julian THUMBOO
Singapore medical journal 2012;53(4):241-243
The incidence of chikungunya infection in Singapore has been on the rise since the first reported case in 2006. Acute polyarthritis, a common manifestation among affected patients, may precede fever and present with debilitating arthritis to rheumatologists, orthopaedists, internists and primary care physicians. The diagnosis of chikungunya infection requires careful history taking and a high index of suspicion, with supporting evidence from the reverse transcription-polymerase chain reaction or the chikungunya IgM serology test. Treatment of chikungunya arthritis usually involves non-steroidal anti-inflammatory drugs. Rarely, polyarthritis in chikungunya may persist even after resolution of the acute infection, necessitating treatment with disease-modifying anti-rheumatic drugs. In this article, we present the different manifestations of chikungunya arthritis in our local setting and review the literature.
Aged
;
Alphavirus Infections
;
complications
;
Anti-Inflammatory Agents, Non-Steroidal
;
therapeutic use
;
Arthritis
;
drug therapy
;
virology
;
Chikungunya Fever
;
Chikungunya virus
;
Female
;
Humans
;
Male
;
Middle Aged
10.A three-month follow up of musculoskeletal manifestions in chikungunya fever.
Gutierrez-Rubio Anna Kristina ; Magbitang Angeline-Therese D. ; Penserga Ester G.
Philippine Journal of Internal Medicine 2014;52(1):1-5
BACKGROUND: Chikungunya virus (CHIKV) is a mosquito- borne alphavirus of the family Togaviridae transmitted to humans by the Aedes spp. mosquitoes, causing Chikungunya Fever (CHIKF).
OBJECTIVE: This study aims to describe the course and outcome of musculoskeletal (MSK) manifestations in patients with CHIKF seen over a three-month period.
DESIGN: This is a prospective descriptive study. Seventy patients with fever, rash, and arthritis seen at the University of the Philippines-Philippine General Hospital and private arthritis clinics were collected from August - December 2012. Demographics and course of arthritis were described.
RESULTS: Seventy patients, 53 (68.6%) female, with a mean age of 39.2 ±13.50 were diagnosed with CHIKF. All cases were from the Metropolitan Manila area. Of these, 15 (21.4%) had family members affected. Twenty-four patients (34.3%) were either employed or students. The most common presenting symptoms were fever (94.3%), arthritis or athralgia (98.6%), and rash (87.1%). The most common joint areas involved were the ankles (60.0%), the wrists (40.0%) and the small joints of the hand (51.4%). Twenty-seven (47.3%) had symmetric arthritis. Thirty- seven cases (52.9%) had arthralgia or arthritis for at least six weeks. By the end of the follow-up period, only four (5.7%) had persistent musculoskeletal symptoms. Age and sex were not found to be factors in determining chronicity of arthritic symptoms (p = 0.104 and p=0.58 respectively). Of the seventy patients, 31 (44. 3%) were confirmed cases of CHIKF-- 29 had (+) CHIKV IgM by ELISA, and two had (+) CHIKV PCR. Twenty- one (67.7%) had persistent arthritis of at least six weeks. Treatment consisted of continuous NSAIDs for at least two weeks and some received steroids. In this subgroup, age and sex were not shown to correlate with chronic arthritis (p=0.47 and p=0.05 respectively).
CONCLUSION: This report on a recent outbreak of CHIKF showed the classic triad of fever, rash, and arthritis. There was no correlation between age and chronicity of arthritic symptoms. Sex, likewise, did not appear to influence chronicity. The disease occurred in family clusters. Patients required continuous treatment with NSAIDs and some had to be given steroids. Most cases resolved by 12 weeks.
Human ; Male ; Female ; Middle Aged ; Adult ; Chikungunya Fever ; Chikungunya Virus ; Togaviridae ; Anti-inflammatory Agents, Non-steroidal ; Arthralgia ; Arthritis ; Exanthema ; Enzyme-linked Immunosorbent Assay